Table 3.
Univariate and multivariable Cox regression models for 90-day ICU mortality
Univariate model | Variable | Univariable hazard ratio | 95% CI | p value |
---|---|---|---|---|
Demographic variablesrow | ||||
CAPA | 1.36 | 1.02–1.81 | <0.001 | |
Age (per 5 years) | 1.24 | 1.17–1.31 | <0.001 | |
Female gender | 1.07 | 0.82–1.39 | 0.607 | |
Study centre | 0.96 | 0.95–0.98 | <0.001 | |
Coexisting conditions | ||||
Number of coexisting conditions | 1.11 | 0.99–1.24 | 0.05 | |
Obesity | 0.77 | 0.58–1.02 | 0.076 | |
Active malignant disease | 1.68 | 1.12–2.51 | 0.013 | |
Solid organ transplantation | 1.89 | 1.04–3.46 | 0.038 | |
Cardiovascular disease | 1.33 | 1.04–1.72 | 0.021 | |
Pulmonary disease | 1.35 | 0.98–1.77 | 0.060 | |
Diabetes mellitus | 1.44 | 1.11–1.86 | –0.001 | |
History of smoking | 1.58 | 1.12-2.24 | 0.001 | |
Maximum Respiratory Treatment | ||||
ECMO | 0.99 | 0.65–1.51 | 0.982 | |
Invasive mechanical ventilation | 1.05 | 0.81–1.35 | 0.708 | |
Non-Invasive ventilation |
0.86 |
0.62–1.19 |
0.361 |
|
Multivariable Model |
Variable |
Multivariable hazard ratio |
95% CI |
p value |
#1 (n = 592) | CAPA | 1.77 | 1.31–2.37 | <0.001 |
Age | 1.04 | 1.03–1.05 | <0.001 | |
#2 (n = 592) | CAPA | 2.23 | 1.66–2.99 | <0.001 |
Study centre | 0.96 | 0.94–0.98 | <0.001 | |
#3 (n = 592) | CAPA | 1.97 | 1.46–2.67 | <0.001 |
Active malignancy | 1.47 | 0.98–2.23 | 0.062 | |
Solid organ transplantation | 1.38 | 0.74–2.58 | 0.304 | |
Cardiovascular disease | 1.19 | 0.92–1.54 | 0.178 | |
Diabetes mellitus | 1.31 | 1.00–1.72 | 0.047 | |
History of smoking | 1.46 | 1.02–2.08 | 0.037 | |
#4 (n = 592) | CAPA | 1.68 | 1.23–2.28 | 0.001 |
Age | 1.04 | 1.03–1.06 | <0.001 | |
Study centre | 0.95 | 0.94–0.97 | <0.001 | |
Active malignancy | 1.30 | 0.86–1.97 | 0.207 | |
Solid organ transplantation | 1.59 | 0.85–2.98 | 0.145 | |
Cardiovascular disease | 0.84 | 0.64–1.09 | 0.204 | |
Diabetes mellitus | 1.36 | 1.04–1.78 | 0.022 | |
History of smoking | 1.50 | 1.04–2.15 | 0.028 |
Abbreviations: CAPA, COVID-19-associated pulmonary aspergillosis; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation.